4-oxo-1,2,3,4-tetrahydroquinazolines. I. Syntheses and pharmacological properties of 2-methyl-3-aryl-4-oxo-1,2,3,4-tetrahydroquinazolines and their 1-acyl derivatives.
D000632:Aminopyrine / Q000627:therapeutic use; D000700:Analgesics / Q000138:chemical synthesis* / Q000627:therapeutic use; D000818:Animals; D000893:Anti-Inflammatory Agents / Q000138:chemical synthesis* / Q000627:therapeutic use; D001463:Barbiturates / Q000494:pharmacology; D001522:Behavior, Animal / Q000187:drug effects; D055598:Chemical Phenomena; D002627:Chemistry, Physical; D004155:Diphenhydramine / Q000627:therapeutic use; D004357:Drug Synergism; D006168:Guinea Pigs; D006634:Histamine H1 Antagonists / Q000138:chemical synthesis* / Q000627:therapeutic use; D007422:Intestines / Q000187:drug effects; D008297:Male; D051379:Mice; D010653:Phenylbutazone / Q000627:therapeutic use; D011799:Quinazolines / Q000008:administration & dosage / Q000138:chemical synthesis* / Q000494:pharmacology / Q000627:therapeutic use / Q000633:toxicity; D051381:Rats
D000700:Analgesics; D000893:Anti-Inflammatory Agents; D001463:Barbiturates; D006634:Histamine H1 Antagonists; D011799:Quinazolines; D000632:Aminopyrine; D004155:Diphenhydramine; D010653:Phenylbutazone